SAPROPTERINE DIPHARMA 500 mg, powder for oral solution 30 sachets
Active ingredients: Sapropterin dihydrochloride, Sapropterin
Commercialized according to BDPMDispensing in France: Prescription only
Powder for oral solution30 sachetsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- SAPROPTERINE DIPHARMA 500 mg, poudre pour solution buvable
- Pharmaceutical form
- poudre pour solution buvable
- Route of administration
- orale
- Presentation description
- 30 sachet(s) polytéréphtalate (PET) aluminium polyéthylène
- Marketing authorisation holder
- DIPHARMA (PAYS-BAS)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 6 Jul 2023
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Prescribed by a hospital doctor
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
64320931CIP73024713CIP133400930247136Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| SAPROPTÉRINEpoudre | 384 mg · un sachet | FT |
| DICHLORHYDRATE DE SAPROPTÉRINEpoudre | 500 mg · un sachet | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The published catalog does not list other packages of similar medicines.